Diet
907 articles
Focus on Joy
Long-term survivor Marisa Harris shares her thoughts on surviving, thriving, and making the most of your time while in treatment.
Meet the Researcher: Hiroyuki Kato, M.D., Ph.D.
Researcher Dr. Hiroyuki Kato has traveled from Japan to Boston for his research on IPMNs and pancreatic cancer.
Let’s Win Pancreatic Cancer Short PSA
Part of winning the battle against pancreatic cancer is to hope. Watch our public service announcement to learn more about Let’s Win.
Let’s Win Pancreatic Cancer Survivors Series—Year Six
Join Let’s Win’s long-term survivors as they share their uplifting stories of treatment, resilience, and life after pancreatic cancer.
Stay in the Moment
Debbie Ryan is a long-term survivor of pancreatic cancer. The now-retired basketball coach applied her coaching philosophy to her treatment.
Truly Grateful
Cedric Robins, Sr., is truly grateful to be a long-term survivor of pancreatic cancer. He knew something wasn’t right and he listened to his body.
Let’s Win! Pancreatic Cancer Survivors Series—Year Three
Let’s Win kicks off Year Three of its Survivors Series of videos. The 2020 videos will feature patients with genetic mutations and more researchers.
Let’s Win! Pancreatic Cancer Survivors Series—Year Five
Every year, long-term survivors share their inspiring stories about surviving pancreatic cancer and thriving after.
Let’s Win! Pancreatic Cancer Survivors Series—Year Four
Our inspiring Survivors video series is entering Year Four. Meet more long-term survivors as well as researchers working for new treatments.
The Diabetes and Pancreatic Cancer Connection
Professor Dr. Suresh Chari explains the link between newly on-set diabetes as an indication of pancreatic cancer. Read Dr. Chari’s findings to learn more.
Standard of Care Plus
Dr. Allyson Ocean explains why pancreatic cancer patients should consider clinical trials, which go beyond standard of care.
Testing an Approved Drug for a Specific Mutation
Researchers are testing a drug combination for melanoma in pancreatic cancer patients with a BRAF genetic mutation.
Focusing on a Drug that Treats Specific Tumor Mutations
A clinical trial tests a signal-inhibiting drug for lung cancers with specific genetic mutations on gastrointestinal cancers with the same tumor mutations.
Testing a Signal-Inhibiting Drug on Tumors with Specific Mutations
A new drug for certain tumor mutations is being tested in a type of clinical trial called a basket trial, which matches tumor genetics and drugs.
Resources
Our extensive collection of web-based and other resources for patients, families, and caregivers provides easy access to information on a wide variety of subjects related to pancreatic cancer. The resources are reviewed and updated periodically to ensure they are current.